Sarepta Therapeutics (SRPT) Earnings Date & Reports

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SRPT is expected to report earnings to fall 65.30% to 22 cents per share on November 04

Sarepta Therapeutics SRPT Stock Earnings Reports

Q3'26

Est.

$0.22

Q2'26

Beat

by $0.42

Q1'26

Beat

by $2.17

Q4'25

Missed

by $2.37

Q3'25

Beat

by $0.57

The last earnings report on August 05 showed earnings per share of 63 cents, beating the estimate of 21 cents. With 837.12K shares outstanding, the current market capitalization sits at 1.91B.

View a ticker or compare two or three

SRPT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days